- Previous Close
73.60 - Open
73.20 - Bid 70.20 x --
- Ask 72.00 x --
- Day's Range
70.10 - 73.20 - 52 Week Range
70.10 - 133.26 - Volume
76,718 - Avg. Volume
53,367 - Market Cap (intraday)
4.342B - Beta (5Y Monthly) -0.14
- PE Ratio (TTM)
38.24 - EPS (TTM)
1.88 - Earnings Date --
- Forward Dividend & Yield 0.98 (1.34%)
- Ex-Dividend Date Apr 11, 2024
- 1y Target Est
--
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.
sunway.cc--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 1271.TWO
View MorePerformance Overview: 1271.TWO
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1271.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1271.TWO
View MoreValuation Measures
Market Cap
4.44B
Enterprise Value
4.42B
Trailing P/E
39.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.54
Price/Book (mrq)
1.38
Enterprise Value/Revenue
5.45
Enterprise Value/EBITDA
23.10
Financial Highlights
Profitability and Income Statement
Profit Margin
12.28%
Return on Assets (ttm)
3.21%
Return on Equity (ttm)
5.40%
Revenue (ttm)
810.99M
Net Income Avi to Common (ttm)
99.6M
Diluted EPS (ttm)
1.88
Balance Sheet and Cash Flow
Total Cash (mrq)
312.16M
Total Debt/Equity (mrq)
8.54%
Levered Free Cash Flow (ttm)
-203.18M